A carregar...
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases
Molecular profiling of metastatic nonsquamous non-small cell lung cancer (NSCLC) is required to guide the treatment strategy. Anaplastic lymphoma kinase (ALK) gene rearrangements are found in approximately 5% of lung adenocarcinomas and are associated with specific clinical features including a high...
Na minha lista:
| Publicado no: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6385324/ https://ncbi.nlm.nih.gov/pubmed/30786826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619831906 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|